Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of cefpodoxime proxetil suspension in China. Welcome to wholesale bulk high quality cefpodoxime proxetil suspension for sale here from our factory. Good service and reasonable price are available.
Cefpodoxime Proxetil Suspension is an oral administration formulation of the third-generation cephalosporin class of antibacterial drugs. Its active ingredient is cefpodoxime proxetil - a precursor drug that can be rapidly hydrolyzed in the gastrointestinal tract to form the antibacterial active compound cefpodoxime. This suspension is prepared by uniformly dispersing fine drug powder into an appropriate aqueous medium. Flavoring agents are often added to improve palatability, and it is particularly suitable for children and patients with difficulty in swallowing. Its pharmacological effect lies in irreversibly inhibiting the synthesis of the cell wall mucopolysaccharide of bacteria, thereby exerting a powerful bactericidal effect. It has high activity against various Gram-positive and Gram-negative bacteria (such as Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis), and is widely used in clinical treatment for mild to moderate infections such as otitis media, tonsillitis, bronchitis, and community-acquired pneumonia. When using it, it is necessary to shake well to ensure accurate dosage and strictly follow the doctor's instructions to complete the course of treatment to prevent the emergence of drug-resistant bacteria.
Additional information of chemical compound:
| Product Name | Cefpodoxime Proxetil Powder | Cefpodoxime Proxetil Tablets | Cefpodoxime Proxetil Liquid | Cefpodoxime Proxetil Capsules |
| Product Type | Powder | Tablets | Liquid | Capsules |
| Product Purity | ≥99% | ≥99% | ≥99% | ≥99% |
| Product Specifications | Customizable | Customizable | Customizable | Customizable |
| Product Package | Customizable | Customizable | Customizable | Customizable |
Our product form
Cefpodoxime Proxetil +. COA
 |
||
Certificate of Analysis |
||
|
Compound name |
Cefpodoxime Proxetil | |
|
CAS No. |
87239-81-4 | |
|
Grade |
Pharmaceutical grade | |
|
Quantity |
Customized | |
|
Packaging standard |
Customized | |
| Manufacturer | Shaanxi BLOOM TECH Co., Ltd | |
|
Lot No. |
20250109001 |
|
|
MFG |
Jan 12th 2025 |
|
|
EXP |
Jan 8th 2029 |
|
|
Structure |
|
|
| TEST STANDARD | GB/T24768-2009 Industry. Stnndard | |
|
Item |
Enterprise standard |
Analysis result |
|
Appearance |
White or almost white powder |
Conformed |
|
Water content |
≤4.5% |
0.30% |
| Loss on drying |
≤1.0% |
0.15% |
|
Heavy Metals |
Pb≤0.5ppm |
N.D. |
|
As≤0.5ppm |
N.D. | |
|
Hg≤0.5ppm |
N.D. | |
|
Cd≤0.5ppm |
N.D. | |
|
Purity (HPLC) |
≥99.0% |
99.5% |
|
Single impurity |
<0.8% |
0.48% |
|
Residue on ignition |
<0.20% |
0.064% |
|
Total microbial count |
≤750cfu/g |
80 |
|
E. Coli |
≤2MPN/g |
N.D. |
|
Salmonella |
N.D. | N.D. |
|
Ethanol (by GC) |
≤5000ppm |
400ppm |
|
Storage |
Store in a sealed, dark and dry place at-20 degrees |
|
|
|
||
Cefpodoxime Proxetil Suspension is an oral third-generation cephalosporin antibiotic prodrug that is converted into cefpodoxime with antibacterial activity by non-specific esterase hydrolysis in the body. It plays an important role in clinical infection treatment due to its broad-spectrum antibacterial activity, especially its strong inhibitory effect on Gram positive and Gram negative bacteria, as well as its stability against β - lactams.
1. Upper respiratory tract infection
(1) Acute otitis media
Acute otitis media is a common disease in children, often caused by bacteria such as Streptococcus pneumoniae and Haemophilus influenzae. Children often experience symptoms such as ear pain, hearing loss, and purulent discharge from the ear canal, which may affect hearing development in severe cases. Cefotaxime ester dry suspension can effectively penetrate the middle ear mucosa, achieve high drug concentrations locally, and inhibit and kill pathogenic bacteria. Clinical studies have shown that for mild to moderate acute otitis media, the use of this medication can significantly alleviate ear pain symptoms, shorten the course of the disease, and improve hearing recovery rate. For example, in a clinical trial targeting acute otitis media in children, the group treated with cefpodoxime axetil dry suspension showed significantly shorter relief time for ear pain and better hearing recovery compared to the control group.
2. Sinusitis
Acute sinusitis: usually caused by upper respiratory tract infection, common pathogens include Streptococcus pneumoniae, Haemophilus influenzae, etc. The patient mainly presents with symptoms such as nasal congestion, purulent nasal discharge, and headache. Cefotaxime ester dry suspension can effectively inhibit the growth and reproduction of these pathogens, reduce the inflammatory response of sinus mucosa, and promote sinus drainage. Multiple clinical studies have confirmed that the drug is highly effective in treating acute sinusitis and can significantly improve patients' clinical symptoms, such as reducing purulent discharge and relieving headaches.
Acute exacerbation of chronic sinusitis: Patients with chronic sinusitis are prone to acute exacerbation when their immune system is weakened or exposed to external stimuli. At this point, inflammation within the sinuses worsens, with symptoms similar to acute sinusitis.
Cefotaxime ester dry suspension can be used to treat pathogenic bacteria during acute attacks, control infections, prevent further spread of inflammation, and reduce the occurrence of complications. Compared with traditional antibiotic treatment, this drug has better tolerance and safety, and can effectively improve the quality of life of patients.
3. Tonsillitis
Acute tonsillitis: mainly caused by bacterial infections such as streptococcus, patients experience severe sore throat, difficulty swallowing, and often accompanied by symptoms such as fever. Cefotaxime ester dry suspension has strong antibacterial activity against streptococcus, which can quickly kill pathogenic bacteria and alleviate tonsillitis. Clinical observations have found that using this drug to treat acute tonsillitis can quickly alleviate sore throat symptoms, shorten fever time, and reduce the risk of complications such as peritonsillar abscess.
Acute exacerbation of chronic tonsillitis: Patients with chronic tonsillitis often have bacterial parasites in the tonsil crypts. When the body's resistance decreases, bacteria multiply in large numbers, leading to acute exacerbation. Cefotaxime ester dry suspension can effectively eliminate pathogenic bacteria in the tonsil crypts, control acute symptoms, and reduce the frequency of attacks. Long term follow-up studies have shown that for patients with recurrent chronic tonsillitis, the use of this medication for preventive treatment can significantly reduce the frequency of attacks.
4. Pharyngitis
Acute pharyngitis: often caused by viral infections, but some patients may also have bacterial infections such as streptococcus and staphylococcus.
The patient's main symptoms are sore throat, dryness, and burning sensation, and the pain intensifies during swallowing. Cefpodoxime Axetil Dry Suspension can be used to treat acute pharyngitis complicated with bacterial infections, by inhibiting and killing pathogenic bacteria, reducing pharyngitis, and relieving symptoms. Clinical practice has proved that the combination of this drug and traditional Chinese patent medicines and simple preparations for clearing away heat and detoxification can improve the therapeutic effect and shorten the course of disease.
Acute exacerbation of chronic pharyngitis: Patients with chronic pharyngitis have a chronic inflammatory state of the pharyngeal mucosa for a long time, which is prone to acute exacerbation when stimulated or infected. Cefotaxime ester dry suspension can be used to treat pathogenic bacteria during acute attacks, control inflammation, and alleviate discomfort in the throat. At the same time, the drug can also reduce secretions in the throat and improve the quality of life for patients.
Lower respiratory tract infection
1. Community acquired pneumonia
Community acquired pneumonia refers to infectious pulmonary parenchymal inflammation that occurs outside of hospitals. Common pathogens include Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Cefotaxime ester dry suspension has good antibacterial activity against these pathogens, effectively inhibiting lung inflammation and reducing symptoms such as cough, sputum production, and fever. Clinical studies have shown that for patients with mild to moderate community-acquired pneumonia, the use of this medication can improve the cure rate, shorten hospitalization time, and reduce medical costs. Compared with traditional antibiotic treatment, this drug has lower resistance and higher safety.
2. Acute exacerbation of chronic bronchitis
Patients with chronic bronchitis have mild symptoms during the stable phase of the condition, but during acute attacks, symptoms such as coughing, sputum production, and wheezing may significantly worsen. Acute attacks are often caused by bacterial infections, with common pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Cefotaxime ester dry suspension can be used to treat these pathogens, control infections, alleviate bronchial mucosal inflammation, and relieve symptoms. Long term use of this medication for preventive treatment can reduce the frequency and severity of acute attacks of chronic bronchitis, and improve the quality of life of patients.
3. Secondary infection in bronchiectasis
The bronchial wall structure of patients with bronchiectasis is damaged, making them prone to recurrent infections. When secondary infection occurs, patients may experience symptoms such as coughing, coughing up large amounts of purulent sputum, and even hemoptysis. Cefotaxime ester dry suspension can effectively inhibit and kill bacteria that cause infections, reduce inflammation of bronchial mucosa, decrease sputum secretion, and improve patients' respiratory function. Clinical studies have shown that for patients with secondary infections caused by bronchiectasis, the use of this drug can significantly reduce the positive rate of sputum bacterial culture and improve the quality of life of patients.
Cystitis:
Cystitis is a common infectious diseases of the urinary system, mainly caused by E. coli and other bacteria. Patients often experience bladder irritation symptoms such as frequent urination, urgency, and pain during urination, and in severe cases, may be accompanied by hematuria. Cefotaxime ester dry suspension can enter urine and reach a high drug concentration in the bladder, effectively killing bacteria that cause infection, relieving symptoms, and promoting the repair of bladder mucosa. Clinical studies have confirmed that the drug has a high efficacy in treating cystitis, can quickly alleviate symptoms such as frequent urination, urgency, and pain, and has a low recurrence rate.
Urethritis
1. Gonococcal urethritis
Gonococcal urethritis is a sexually transmitted disease caused by Neisseria gonorrhoeae. Patients experience increased purulent urethral discharge, accompanied by symptoms such as urethral pain and itching. Cefpodoxime proxetil suspension has strong antibacterial activity against Neisseria gonorrhoeae, which can quickly kill Neisseria gonorrhoeae, alleviate urethritis, and relieve symptoms. For acute simple gonococcal urethritis, the use of this medication can achieve a high cure rate with minimal side effects.
2. Non gonococcal urethritis
Non gonococcal urethritis is mainly caused by pathogens such as mycoplasma and chlamydia, and some patients may also be caused by sensitive bacteria. Cefotaxime ester dry suspension has antibacterial effects on some sensitive bacteria that cause non gonococcal urethritis, and can be used to treat non gonococcal urethritis caused by these sensitive bacteria.
Clinical observations have found that the combination of this drug with other drugs targeting mycoplasma and chlamydia can improve treatment efficacy and shorten the course of treatment.
3. Pyelonephritis
Pyelonephritis is an inflammation of the renal pelvis and renal parenchyma caused by pathogenic microorganisms, often accompanied by lower urinary tract infections. Patients may experience symptoms such as fever, chills, lower back pain, frequent urination, urgency to urinate, and painful urination. Cefotaxime ester dry suspension can reach the kidneys through blood circulation, exerting antibacterial effects in kidney tissue, controlling infections, reducing kidney inflammation, and protecting kidney function. Clinical studies have shown that for patients with mild to moderate pyelonephritis, the use of this medication can improve the cure rate and reduce the occurrence of complications.
Skin and soft tissue infections
1. Folliculitis
Folliculitis is an inflammatory response of hair follicles, which can be caused by bacteria, fungi, etc. Bacterial folliculitis is commonly manifested as red papules around hair follicles, sometimes accompanied by pustules, itching or pain. Cefotaxime ester dry suspension has antibacterial effects on common bacteria that cause folliculitis, such as Staphylococcus aureus, and can promote the resolution of folliculitis. Clinical practice has proven that using this drug to treat folliculitis can quickly alleviate symptoms, reduce pustule formation, and promote hair follicle repair.
2. Boil
Boil is an acute bacterial suppurative inflammation of a single hair follicle and its surrounding tissue. When infected and affecting multiple hair follicles, it is called a boil. At the beginning of the boil, it is a red papule that gradually increases in size, becomes soft in the center, and a yellow white pus head appears at the top.
After rupture, pus can be discharged to heal. Cefotaxime ester dry suspension can control the infection of boils, prevent the spread of inflammation, and promote the absorption and healing of boils. For larger boils, while using this medication for treatment, physical therapy methods such as local hot compress can be combined to improve the treatment effect.
3. Carbuncle
An abscess is an acute bacterial purulent inflammation that occurs simultaneously in multiple adjacent hair follicles and their surrounding tissues, with a larger lesion area than a boil. The patient may experience local redness, swelling, and pain, which may be accompanied by systemic symptoms such as fever. Cefotaxime ester dry suspension can effectively inhibit and kill bacteria that cause abscesses, reduce inflammatory reactions, and promote healing of the affected area. For severe carbuncle patients, cefpodoxime proxetil suspension may be necessary to use a combination of surgical incision and drainage methods, as well as the use of this medication for anti infective treatment.
4. Dan poison
Dandelion is an infection that affects the superficial lymphatic vessels of the dermis, mainly caused by Streptococcus pyogenes. The patient's skin suddenly turns red, with a color like cinnabar and clear edges, accompanied by symptoms such as high fever and chills. Cefotaxime ester dry suspension has good antibacterial activity against Streptococcus, which can control the infection of erysipelas, alleviate symptoms, and prevent the condition from worsening. Clinical studies have shown that early use of this drug to treat erysipelas can quickly alleviate symptoms such as skin redness, swelling, and pain, and shorten the course of the disease.
5. Cellulitis
Cellulitis is an acute diffuse purulent infection of subcutaneous, fascial, intermuscular or deep loose connective tissue. The patient may experience redness, swelling, heat, and pain locally, with unclear boundaries. In severe cases, it can lead to systemic infection symptoms.
Cefotaxime ester dry suspension can inhibit bacterial cell wall synthesis, kill bacteria that cause cellulitis, control inflammation spread, and promote tissue repair. For patients with extensive cellulitis, combination therapy with other antibiotics or surgical treatment may be necessary.
6. Lymphangitis
Lymphatic lymphangitis is the invasion of pathogenic bacteria into the lymphatic system from damaged skin, mucous membranes, or other infected areas, leading to inflammation of lymphatic vessels and surrounding tissues. Patients may experience red lines along the lymphatic vessels, local pain and tenderness, accompanied by symptoms such as fever. Cefotaxime ester dry suspension can effectively treat lymphangitis, reduce inflammatory reactions, and alleviate symptoms. During the treatment process, attention should be paid to rest, raising the affected limb, and promoting lymphatic return.
7. Purulent paronychia
Purulent paronychia is a purulent inflammation of the nail groove and surrounding tissues, often caused by minor trauma or short nail trimming. The patient has redness, swelling, and pain in the nail groove, and in severe cases, an abscess may form. Cefotaxime ester dry suspension can control the infection of paronychia, promote inflammation resolution, prevent abscess formation or promote abscess absorption. For patients who have already developed abscesses, incision and drainage surgery should be performed, and the drug should be used for anti infective treatment.
8. Subcutaneous abscess
Subcutaneous abscess is a purulent infection of subcutaneous tissue, which can be caused by bacterial invasion after skin damage. The patient has a locally swollen and painful lump that gradually softens in the center, with a wave like sensation. After rupture, pus can be discharged. Cefpodoxime proxetil suspension can inhibit and kill bacteria that cause subcutaneous abscesses, promote the absorption and healing of abscesses. For larger subcutaneous abscesses, incision and drainage surgery is required, and the drug is used for anti infective treatment after surgery.
Hot Tags: cefpodoxime proxetil suspension, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale